Cargando…
Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis
Peritoneal dialysis (PD) is an efficient renal replacement therapy for patients with end-stage renal disease. Even if it ensures an outcome equivalent to hemodialysis and a better quality of life, in the long-term, PD is associated with the development of peritoneal fibrosis and the consequents pati...
Autores principales: | Masola, Valentina, Bonomini, Mario, Borrelli, Silvio, Di Liberato, Lorenzo, Vecchi, Luigi, Onisto, Maurizio, Gambaro, Giovanni, Palumbo, Roberto, Arduini, Arduino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102299/ https://www.ncbi.nlm.nih.gov/pubmed/35563220 http://dx.doi.org/10.3390/ijms23094831 |
Ejemplares similares
-
Mild sodium reduction in peritoneal dialysis solution improves hypertension in end stage kidney disease: a case-report study
por: Vecchi, Luigi, et al.
Publicado: (2021) -
How to Improve the Biocompatibility of Peritoneal Dialysis Solutions (without Jeopardizing the Patient’s Health)
por: Bonomini, Mario, et al.
Publicado: (2021) -
Proteomic Research in Peritoneal Dialysis
por: Bonomini, Mario, et al.
Publicado: (2020) -
Biological Effects of XyloCore, a Glucose Sparing PD Solution, on Mesothelial Cells: Focus on Mesothelial-Mesenchymal Transition, Inflammation and Angiogenesis
por: Masola, Valentina, et al.
Publicado: (2021) -
Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal Dialysis
por: Bonomini, Mario, et al.
Publicado: (2019)